proxyvotesnow.com

Home › Upcoming votes › GRI Bio, Inc.

GRI Bio, Inc. Annual Meeting, November 4, 2026: Ballot and Results

This meeting took place on November 4, 2026. GRI Bio, Inc. reported the official results on Form 8-K, filed November 4, 2026 (read it on EDGAR); they are listed below.

The deadline as the proxy statement states it: “vote must be received by 11:59 p.m. Eastern Time on November 3, 2026”. Shares held through a bank, a broker or a company plan can have a different deadline; the voting instruction form says.

Read the proxy statement on EDGAR

What’s on the ballot

Ballot read from the proxy statement and checked. As listed in GRI Bio, Inc.’s proxy statement, with the board’s recommendation on each item.

#ItemProposed byBoard recommendsLast year (same kind of item)
1 Election of Directors
Director election
Board For —
2 Ratification of Appointment of Independent Registered Public Accounting Firm
Auditor
Board For —
3 Approval of an Amendment and Restatement to the Company's Amended and Restated 2018 Equity Incentive Plan Board For —
4 Approval of a Postponement or Adjournment of the Annual Meeting, if Necessary, to Solicit Additional Proxies
Adjournment
Board For —

Last year’s official results

From GRI Bio, Inc.’s Form 8-K, filed January 15, 2026, for the meeting held January 15, 2026 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.

ItemSupport (of votes cast)Reported outcome
1. The proposal to approve an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to effect a reverse 87%Approved
2. Proposal to approve a postponement or adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not su86%Approved

Official results of this meeting

ItemSupport (of votes cast)Reported outcome
Elect Director: W. Marc Hertz, Ph.D.86%—
Elect Director: David Szekeres85%—
2. Ratification of the appointment of WithumSmith+Brown, PC as the Company's independent registered public accounting firm for the fiscal ye97%—
3. Approval of an amendment and restatement to the Company's Amended and Restated 2018 Equity Incentive Plan to (i) increase the aggregate n57%—
4. Approval of any postponement or adjournment of the Annual Meeting, from time to time, if necessary to solicit additional proxies if there94%—

Filings for this meeting

About this page

The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.